Cover Image
市場調查報告書

Sun Pharmaceutical Industries Limited - 產品平台評估

Sun Pharmaceutical Industries Limited - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 207945
出版日期 內容資訊 英文 44 Pages
訂單完成後即時交付
價格
Back to Top
Sun Pharmaceutical Industries Limited - 產品平台評估 Sun Pharmaceutical Industries Limited - Product Pipeline Review - 2014
出版日期: 2014年03月31日 內容資訊: 英文 44 Pages
簡介

Sun Pharmaceutical Industries Limited 是綜合性專業製藥公司,提供網羅大範圍的學名藥製劑處方服務。其提供產品可大致區分為製劑及醫藥品原料藥(APIs)二種。

本報告提供Sun Pharmaceutical Industries Limited的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Sun Pharmaceutical Industries Limited 基本資料

Sun Pharmaceutical Industries Limited 概要

  • 主要資訊
  • 企業資料

Sun Pharmaceutical Industries Limited :R&D概要

  • 主要的治療範圍

Sun Pharmaceutical Industries Limited :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Sun Pharmaceutical Industries Limited :開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Sun Pharmaceutical Industries Limited :藥物簡介

  • baclofen ER
  • IP-033
  • latanoprost
  • Sun-0597
  • SUN-1334 H
  • docetaxel
  • SUN-09
  • SUN-09 Slow Release
  • SUN-44
  • Sun-K706
  • SUN-L731
  • Therapeutics For Ocular Diseases

Sun Pharmaceutical Industries Limited :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Sun Pharmaceutical Industries Limited :最近的開發平台趨勢

Sun Pharmaceutical Industries Limited :暫停中的計劃

Sun Pharmaceutical Industries Limited :企業發表

Sun Pharmaceutical Industries Limited :總公司和子公司的所地

Sun Pharmaceutical Industries Limited :主要製造設備

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC04718CDB

Global Markets Direct's, 'Sun Pharmaceutical Industries Limited - Product Pipeline Review - 2014', provides an overview of the Sun Pharmaceutical Industries Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sun Pharmaceutical Industries Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Sun Pharmaceutical Industries Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Sun Pharmaceutical Industries Limited's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Sun Pharmaceutical Industries Limited's pipeline products

Reasons to buy

  • Evaluate Sun Pharmaceutical Industries Limited's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Sun Pharmaceutical Industries Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Sun Pharmaceutical Industries Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Sun Pharmaceutical Industries Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sun Pharmaceutical Industries Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Sun Pharmaceutical Industries Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Sun Pharmaceutical Industries Limited Snapshot
    • Sun Pharmaceutical Industries Limited Overview
    • Key Information
    • Key Facts
  • Sun Pharmaceutical Industries Limited - Research and Development Overview
    • Key Therapeutic Areas
  • Sun Pharmaceutical Industries Limited - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Sun Pharmaceutical Industries Limited - Pipeline Products Glance
    • Sun Pharmaceutical Industries Limited - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Sun Pharmaceutical Industries Limited - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Sun Pharmaceutical Industries Limited - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Sun Pharmaceutical Industries Limited - Drug Profiles
    • baclofen ER
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IP-033
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • latanoprost
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Sun-0597
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SUN-1334 H
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • docetaxel
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SUN-09
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SUN-09 Slow Release
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SUN-44
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Sun-K706
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SUN-L731
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Therapeutics For Ocular Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Sun Pharmaceutical Industries Limited - Pipeline Analysis
    • Sun Pharmaceutical Industries Limited - Pipeline Products by Target
    • Sun Pharmaceutical Industries Limited - Pipeline Products by Route of Administration
    • Sun Pharmaceutical Industries Limited - Pipeline Products by Molecule Type
    • Sun Pharmaceutical Industries Limited - Pipeline Products by Mechanism of Action
  • Sun Pharmaceutical Industries Limited - Recent Pipeline Updates
  • Sun Pharmaceutical Industries Limited - Dormant Projects
  • Sun Pharmaceutical Industries Limited - Company Statement
  • Sun Pharmaceutical Industries Limited - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Sun Pharmaceutical Industries Limited - Key Manufacturing Facilities
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Sun Pharmaceutical Industries Limited, Key Information
  • Sun Pharmaceutical Industries Limited, Key Facts
  • Sun Pharmaceutical Industries Limited - Pipeline by Indication, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline by Stage of Development, 2014
  • Sun Pharmaceutical Industries Limited - Monotherapy Products in Pipeline, 2014
  • Sun Pharmaceutical Industries Limited - Phase III, 2014
  • Sun Pharmaceutical Industries Limited - Phase II, 2014
  • Sun Pharmaceutical Industries Limited - Phase I, 2014
  • Sun Pharmaceutical Industries Limited - Preclinical, 2014
  • Sun Pharmaceutical Industries Limited - Discovery, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline by Target, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline by Route of Administration, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline by Molecule Type, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline Products by Mechanism of Action, 2014
  • Sun Pharmaceutical Industries Limited - Recent Pipeline Updates, 2014
  • Sun Pharmaceutical Industries Limited - Dormant Developmental Projects,2014
  • Sun Pharmaceutical Industries Limited, Other Locations
  • Sun Pharmaceutical Industries Limited, Subsidiaries
  • Sun Pharmaceutical Industries Limited, Key Manufacturing Facilities

List of Figures

  • Sun Pharmaceutical Industries Limited - Pipeline by Top 10 Indication, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline by Stage of Development, 2014
  • Sun Pharmaceutical Industries Limited - Monotherapy Products in Pipeline, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline by Top 10 Target, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline by Top 10 Route of Administration, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline by Top 10 Molecule Type, 2014
  • Sun Pharmaceutical Industries Limited - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top